ASPN Stock - Aspen Aerogels, Inc.
Unlock GoAI Insights for ASPN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial β’ No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $452.70M | $238.72M | $180.36M | $121.62M | $100.27M |
| Gross Profit | $182.90M | $56.92M | $4.98M | $9.94M | $14.59M |
| Gross Margin | 40.4% | 23.8% | 2.8% | 8.2% | 14.6% |
| Operating Income | $54.53M | $-49,203,000 | $-79,245,000 | $-40,599,000 | $-21,569,000 |
| Net Income | $13.38M | $-45,811,000 | $-82,738,000 | $-37,094,000 | $-21,809,000 |
| Net Margin | 3.0% | -19.2% | -45.9% | -30.5% | -21.7% |
| EPS | $0.17 | $-0.66 | $-2.19 | $-0.92 | $-0.45 |
Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and building materials markets in the United States, Asia, Canada, Europe, and Latin America. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; Pyrogel HPS for applications within the power generation market; Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; and Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production. It also offers Spaceloft Grey and Spaceloft A2 for use in the building materials market; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 11th 2025 | Barclays | Downgrade | Underweight | $16 |
| May 29th 2025 | Barclays | Downgrade | Equal Weight | $7 |
| May 8th 2025 | Oppenheimer | Downgrade | Perform | - |
| March 7th 2025 | TD Cowen | Resumed | Buy | $11 |
| February 13th 2025 | Seaport Research Partners | Downgrade | Neutral | - |
| August 6th 2024 | Barclays | Initiation | Overweight | $27 |
| March 6th 2024 | ROTH MKM | Initiation | Buy | $22 |
| March 20th 2023 | The Benchmark Company | Upgrade | Buy | $14 |
| October 21st 2022 | Canaccord Genuity | Resumed | Buy | $20 |
Earnings History & Surprises
ASPNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | β | β | β | β |
Q1 2026 | Feb 11, 2026 | $-0.24 | β | β | β |
Q4 2025 | Nov 6, 2025 | $-0.21 | $-0.06 | +72.1% | β BEAT |
Q3 2025 | Aug 7, 2025 | $-0.12 | $-0.04 | +66.7% | β BEAT |
Q2 2025 | May 8, 2025 | $-0.07 | $-0.06 | +14.3% | β BEAT |
Q1 2025 | Feb 12, 2025 | $0.04 | $0.15 | +275.0% | β BEAT |
Q4 2024 | Nov 6, 2024 | $-0.10 | $0.11 | +210.0% | β BEAT |
Q3 2024 | Aug 7, 2024 | $0.05 | $0.21 | +320.0% | β BEAT |
Q2 2024 | May 1, 2024 | $-0.13 | $0.01 | +107.7% | β BEAT |
Q1 2024 | Feb 12, 2024 | $-0.12 | $-0.01 | +91.7% | β BEAT |
Q4 2023 | Nov 1, 2023 | $-0.29 | $-0.19 | +34.5% | β BEAT |
Q3 2023 | Aug 2, 2023 | $-0.36 | $-0.22 | +38.9% | β BEAT |
Q2 2023 | May 3, 2023 | $-0.41 | $-0.24 | +41.5% | β BEAT |
Q1 2023 | Feb 16, 2023 | $-0.30 | $-0.20 | +33.3% | β BEAT |
Q1 2023 | Feb 15, 2023 | β | $-0.00 | β | β |
Q4 2022 | Oct 26, 2022 | $-0.54 | $-0.75 | -38.9% | β MISS |
Q3 2022 | Jul 27, 2022 | $-0.57 | $-0.68 | -19.3% | β MISS |
Q2 2022 | Apr 27, 2022 | $-0.47 | $-0.59 | -25.5% | β MISS |
Q1 2022 | Feb 17, 2022 | $-0.30 | $-0.50 | -66.7% | β MISS |
Q4 2021 | Oct 28, 2021 | $-0.25 | $-0.35 | -40.0% | β MISS |
Latest News
Canaccord Genuity Maintains Buy on Aspen Aerogels, Lowers Price Target to $5
β NeutralBarclays Maintains Underweight on Aspen Aerogels, Lowers Price Target to $4
π NegativeAspen Aerogels shares are trading lower after the company lowered its full-year earnings and sales guidance.
π NegativeAspen Aerogels Lowers FY2025 GAAP EPS Guidance from $(3.86)-$(3.73) to $(4.15)-$(4.05) vs $(3.82) Est; Lowers FY2025 Sales Guidance from $297.000M-$317.000M to $270.000M-$280.000M vs $303.592M Est
π NegativeAspen Aerogels Q3 Adj. EPS $(0.06) Misses $(0.03) Estimate, Sales $73.017M Beat $71.844M Estimate
β NeutralFrequently Asked Questions about ASPN
What is ASPN's current stock price?
What is the analyst price target for ASPN?
What sector is Aspen Aerogels, Inc. in?
What is ASPN's market cap?
Does ASPN pay dividends?
Similar Stocks
Industrials SectorExplore stocks similar to ASPN for comparison